Back to Results
First PageMeta Content
Stock market / Financial ratios / Valuation / P/E ratio / Growth stock / Earnings growth / Value investing / Fundamental analysis / P/B ratio / Financial economics / Finance / Investment


  Guru Stock Report MERCK & CO., INC. (NYSE: MRK) INDUSTRY: Biotechnology & Drugs
Add to Reading List

Document Date: 2015-03-06 14:58:27

Open Document

File Size: 201,04 KB

Share Result on Facebook

Company

MERCK & CO. INC. / LEADING INDUSTRIES / THE INDUSTRY / Kemper-Dreman High-Return Equity Fund / Standard & Poor's / Strong Buy / Guru Stock Report MERCK & CO. INC. / the Motley Fool / COMPANY PROFILE Merck & Co. Inc. / /

Currency

USD / /

/

Event

Earnings Guidance / Earnings Announcement / Dividend Issuance / Business Partnership / /

IndustryTerm

animal health products / human health pharmaceutical / consumer care products / treatment of human disorders / vaccine products / activities/services / health solutions / investment banking relationships / sun care products / /

MarketIndex

S&P 500 / S&P / /

Organization

Fidelity Magellan Fund / /

Person

John Neff / David Dreman Book / Validea / Kenneth Fisher / Martin Zweig Growth / Martin Zweig / Peter Lynch / Joseph Piotroski / Benjamin Graham / David Dreman / Shaughnessy Low / Ben Graham / James P. O'Shaughnessy / Warren Buffett / /

Position

financial analyst / manager / investment advisor / renowned money manager / newsletter writer / premier / individual investment advisors / investment columnist / /

PublishedMedium

Forbes / /

TVShow

Wall Street Week / /

Technology

Biotechnology / /

URL

http /

SocialTag